(BROS) Dutch Bros - Overview
Stock: Coffee, Energy Drink, Smoothies, Shakes
| Risk 5d forecast | |
|---|---|
| Volatility | 59.5% |
| Relative Tail Risk | -14.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.71 |
| Alpha | -62.39 |
| Character TTM | |
|---|---|
| Beta | 1.620 |
| Beta Downside | 1.692 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.17% |
| CAGR/Max DD | 0.32 |
EPS (Earnings per Share)
Revenue
Primary Risks
P/E ratio: 83.7656
Description: BROS Dutch Bros January 03, 2026
Dutch Bros Inc. (NYSE:BROS) operates a network of drive-thru coffee shops across the United States, split between Company-Operated Shops and franchised locations. The brand portfolio includes Dutch Bros, Dutch Bros Coffee, Dutch Bros Rebel, and Blue Rebel, all sold primarily through physical drive-thru outlets and online ordering channels.
Founded in 1992 and headquartered in Grants Pass, Oregon, the company reported FY 2023 revenue of approximately $1.5 billion and grew its store count to roughly 800 locations, with franchisees now accounting for about 30 percent of total outlets. Same-store sales rose ~15 percent year-over-year, driven by higher average ticket size (≈ $7.20) and strong demand for the higher-margin Rebel energy-drink line.
Key economic drivers for Dutch Bros include discretionary consumer spending trends, coffee bean price volatility, and labor-cost inflation-factors that disproportionately affect drive-thru concepts with lower overhead than full-service cafés. At the sector level, the continued shift toward on-the-go coffee consumption and the expansion of franchise models are boosting scalability and cash-flow generation for players like Dutch Bros.
For a deeper, data-rich analysis of Dutch Bros’ valuation and scenario modeling, consult the ValueRay platform.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 79.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.82 > 1.0 |
| NWC/Revenue: 7.13% < 20% (prev 12.09%; Δ -4.95% < -1%) |
| CFO/TA 0.10 > 3% & CFO 295.5m > Net Income 79.8m |
| Net Debt (-32.8m) to EBITDA (265.2m): -0.12 < 3 |
| Current Ratio: 1.49 > 1.5 & < 3 |
| Outstanding Shares: last quarter (127.4m) vs 12m ago 10.58% < -2% |
| Gross Margin: 25.88% > 18% (prev 0.27%; Δ 2561 % > 0.5%) |
| Asset Turnover: 59.46% > 50% (prev 51.22%; Δ 8.24% > 0%) |
| Interest Coverage Ratio: 5.68 > 6 (EBITDA TTM 265.2m / Interest Expense TTM 28.0m) |
Altman Z'' 0.80
| A: 0.04 (Total Current Assets 357.4m - Total Current Liabilities 240.5m) / Total Assets 3.01b |
| B: 0.03 (Retained Earnings 99.5m / Total Assets 3.01b) |
| C: 0.06 (EBIT TTM 159.0m / Avg Total Assets 2.76b) |
| D: 0.05 (Book Value of Equity 99.6m / Total Liabilities 2.11b) |
| Altman-Z'' Score: 0.80 = B |
Beneish M -2.55
| DSRI: 1.36 (Receivables 18.4m/10.6m, Revenue 1.64b/1.28b) |
| GMI: 1.03 (GM 25.88% / 26.55%) |
| AQI: 1.05 (AQ_t 0.32 / AQ_t-1 0.31) |
| SGI: 1.28 (Revenue 1.64b / 1.28b) |
| TATA: -0.07 (NI 79.8m - CFO 295.5m) / TA 3.01b) |
| Beneish M-Score: -2.55 (Cap -4..+1) = A |
What is the price of BROS shares?
Over the past week, the price has changed by -8.25%, over one month by -20.52%, over three months by -4.05% and over the past year by -40.50%.
Is BROS a buy, sell or hold?
- StrongBuy: 10
- Buy: 5
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BROS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 77.1 | 58% |
| Analysts Target Price | 77.1 | 58% |
BROS Fundamental Data Overview February 19, 2026
P/E Forward = 65.3595
P/S = 5.3849
P/B = 10.0047
Revenue TTM = 1.64b USD
EBIT TTM = 159.0m USD
EBITDA TTM = 265.2m USD
Long Term Debt = 196.3m USD (from longTermDebt, last quarter)
Short Term Debt = 40.3m USD (from shortTermDebt, last quarter)
Debt = 236.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -32.8m USD (from netDebt column, last quarter)
Enterprise Value = 8.79b USD (8.82b + Debt 236.6m - CCE 269.4m)
Interest Coverage Ratio = 5.68 (Ebit TTM 159.0m / Interest Expense TTM 28.0m)
EV/FCF = 161.5x (Enterprise Value 8.79b / FCF TTM 54.4m)
FCF Yield = 0.62% (FCF TTM 54.4m / Enterprise Value 8.79b)
FCF Margin = 3.32% (FCF TTM 54.4m / Revenue TTM 1.64b)
Net Margin = 4.87% (Net Income TTM 79.8m / Revenue TTM 1.64b)
Gross Margin = 25.88% ((Revenue TTM 1.64b - Cost of Revenue TTM 1.21b) / Revenue TTM)
Gross Margin QoQ = 24.15% (prev 25.21%)
Tobins Q-Ratio = 2.92 (Enterprise Value 8.79b / Total Assets 3.01b)
Interest Expense / Debt = 3.14% (Interest Expense 7.42m / Debt 236.6m)
Taxrate = 6.37% (1.99m / 31.1m)
NOPAT = 148.9m (EBIT 159.0m * (1 - 6.37%))
Current Ratio = 1.49 (Total Current Assets 357.4m / Total Current Liabilities 240.5m)
Debt / Equity = 0.35 (Debt 236.6m / totalStockholderEquity, last quarter 680.8m)
Debt / EBITDA = -0.12 (Net Debt -32.8m / EBITDA 265.2m)
Debt / FCF = -0.60 (Net Debt -32.8m / FCF TTM 54.4m)
Total Stockholder Equity = 643.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.90% (Net Income 79.8m / Total Assets 3.01b)
RoE = 12.41% (Net Income TTM 79.8m / Total Stockholder Equity 643.2m)
RoCE = 18.95% (EBIT 159.0m / Capital Employed (Equity 643.2m + L.T.Debt 196.3m))
RoIC = 17.23% (NOPAT 148.9m / Invested Capital 864.2m)
WACC = 11.65% (E(8.82b)/V(9.06b) * Re(11.88%) + D(236.6m)/V(9.06b) * Rd(3.14%) * (1-Tc(0.06)))
Discount Rate = 11.88% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 30.04%
[DCF Debug] Terminal Value 55.79% ; FCFF base≈42.5m ; Y1≈27.9m ; Y5≈12.7m
Fair Price DCF = 1.48 (EV 154.8m - Net Debt -32.8m = Equity 187.6m / Shares 127.1m; r=11.65% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 72.54 | EPS CAGR: 46.91% | SUE: 3.91 | # QB: 3
Revenue Correlation: 98.40 | Revenue CAGR: 33.02% | SUE: 2.52 | # QB: 7
EPS next Quarter (2026-03-31): EPS=0.16 | Chg30d=-0.024 | Revisions Net=-8 | Analysts=17
EPS current Year (2026-12-31): EPS=0.90 | Chg30d=-0.002 | Revisions Net=-4 | Growth EPS=+18.1% | Growth Revenue=+24.7%
EPS next Year (2027-12-31): EPS=1.19 | Chg30d=+0.002 | Revisions Net=-2 | Growth EPS=+32.5% | Growth Revenue=+23.2%